MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    An international consensus statement for rehabilitation care in Parkinson’s disease

    J. Goldman, D. Volpe, T. Ellis, M. Hirsch, J. Johnson, J. Wood, A. Aragon, R. Biundo, A. Dirocco, G. Kasman, R. Iansek, J. Miyasaki, V. Mcconvey, M. Munneke, S. Pinto, K. St Clair, S. Toledo, M. York, R. Todaro, N. Yarab, K. Wallock (Chicago, USA)

    Objective: To develop a consensus statement regarding the incorporation of rehabilitation in Parkinson’s (PD) care. Background: As a complex, progressive disorder, PD can impact daily…
  • 2023 International Congress

    Neuropsychiatric Symptoms in Early-Onset Parkinson’s Disease

    C. Piat, E. Camerucci, A. Mullan, K. Ghoniem, J. Jacobson, G. Patanè, P. Turcano, R. Savica (Rochester, USA)

    Objective: To describe the neuropsychiatric symptoms of Early-Onset Parkinson’s Disease (EOPD) patients in an incident cohort study from 1991 to 2010 in Olmsted County, Minnesota…
  • 2023 International Congress

    Effects on voice sound level and brain connectivity after HiCommunication: a novel speech and communication treatment for Parkinson’s disease

    H. Steurer, F. Albrecht, A. Razi, J. Körner Gustafsson, E. Franzén, E. Schalling (Stockholm, Sweden)

    Objective: This study aimed to evaluate the clinical relevance of effects on voice sound level (Lv) as well as brain connectivity using resting-state functional MRI…
  • 2023 International Congress

    Chronotropic incompetence – a possible marker of severe Parkinson’s disease phenotype?

    M. Andréasson, P. Svenningsson (Stockholm, Sweden)

    Objective: Perform a retrospective analysis of patients with Parkinson’s disease (PD) who previously have undergone a cardiac stress test, with the aim of comparing clinical…
  • 2023 International Congress

    A Systematic Review of the Type, Timing, Frequency and Durability of Effect in Parkinson’s Disease Physical Therapy

    M. El Hayek, J. Jofili Lopes, J. Lelaurin, A. Abi Nehme, K. Au, M. Okun, R. Salloum (Gainesville, USA)

    Objective: To evaluate all current evidence on the types, timing, frequency, duration, and outcomes of physical therapy (PT) regimens applied in Parkinson’s disease (PD). Background:…
  • 2023 International Congress

    A comparative analysis of vegetative disorders in Parkinson`s disease and vascular parkinsonism.

    R. Juraev, R. Matmurodov, K. Khalimova (Tashkent, Uzbekistan)

    Objective: Comparative analysis of vegetative disorders (VD)  in Parkinson's disease and vascular parkinsonism. Background: Vegetative disorders (VD) are one of the most common nonmotor disorders…
  • 2023 International Congress

    Initial clinical experience with levodopa-entacapone-carbidopa intestinal gel infusion (LECIG) for the management of advanced Parkinson´s disease in Croatia

    P. Bago Rožanković, S. Lasić, F. Borovečki, S. Telarović, R. Perković, V. Vuletić, O. Perković, V. Rački, S. Tomić (Zagreb, Croatia)

    Objective: To report preliminary results of a 12-week, prospective, multicenter, observational study of the efficacy and safety of LECIG for the treatment of advanced Parkinson´s…
  • 2023 International Congress

    Genome-wide association identifies novel etiological insights associated with Parkinson’s Disease in African and African admixed populations

    M. Rizig, S. Bandres Ciga, M. Makarious, O. Ojo, O. Okunoye, K. Levine, E. Sidransky, N. Tayebi, P. Wild Crea, C. Blauwendraat, H. Houlden, J. Hardy, A. Singleton, N. Okubadejo (London, United Kingdom)

    Objective: To provide a genome-wide association study (GWAS)- based insight into the genetics of Parkinson’s disease (PD) in Africans and African admixed populations. Background: Understanding…
  • 2023 International Congress

    Early onset of efficacy during titration in US phase 3 open-label InfusON trial of apomorphine subcutaneous infusion for Parkinson’s disease motor fluctuations

    S. Isaacson, G. Ceresoli-Borroni, A. Espay, R. Pahwa, P. Agarwal, H. Shill, J. Hui, K. Dashtipour, M. Lew, P. Qin, P. Lewitt (Boca Raton, USA)

    Objective: Evaluate safety/onset of efficacy during titration of continuous subcutaneous apomorphine infusion (CSAI) for motor fluctuations in U.S. outpatients with Parkinson’s disease (PD). Background: Global…
  • 2023 International Congress

    Clinical Improvement and drastic reduction of Equivalent Dose of Levodopa (LEDD) in an Advanced Parkinson’s Disease Patient after Levodopa/Entacapone/Carbidopa Intestinal Gel (LECIG) Treatment

    G. Tabar Comellas, MI. Morales Casado, JC. Segundo-Rodríguez, N. Lopez Ariztegui (Toledo, Spain)

    Objective: Describe a patient in which after starting continuous infusion of LECIG a large reduction of the LEDD  is achieved. Background: Gastroparesis (GP) is one…
  • « Previous Page
  • 1
  • …
  • 162
  • 163
  • 164
  • 165
  • 166
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley